STC2 and SLC2A1 were both involved in biological behaviors of many cancers, especially in HCC, through the modulation of mTOR signaling pathways (Wei et al., 2017; Wu et al., 2017). Here, SLC2A1 is linked to hepatocellular carcinoma.